Agenda
March 20, 2024
8:45 Structure of the Symposium: Max O’Donnell
8:55 Welcome to Columbia and Harlem: Wafaa El-Sadr
9:10 Greeting Symposium Attendees: Max O’Donnell and Barun Mathema
9:20 Kogieleum Naidoo: Introduction
9:30 Norbert Ndjeka: New drugs for drug-resistant TB in a high TB burden setting: Leadership, opportunities and the challenges of emerging drug resistance in South Africa
10:00 Kelly Dooley: The Tuberculosis Drug Development Pipeline – Harnessing Current (& Future) Knowledge to Address Highly Drug-Resistant TB
10:45 Tenzin Kunor: The importance of TB-affected community narratives and experiences in framing the challenges
11:00 Timothy Walker: Molecular tools for diagnosing drug resistance: where have we got to?
11:15 Amrita Daftary: Social dimensions of drug-resistant TB
11:30 David Dowdy: Emergence of resistance to BDQ: considerations from a modeling perspective
1:30 Viewpoints and Controversies in New Treatment Regimens
Chair: Robert Horsburgh
Panel Members:
Puneet Dewan
Ma. Tarcela S. Gler
Michelle Larsen
Carole Mitnick
Paran Sarimita Winarni
Morten Ruhwald
2:45 Community and TB Champions Perspectives on Emerging Resistance
Chairs: Jonathan Stillo, Amrita Daftary
Panel Members:
Stephen Anguva Shikoli
Phumeza Tisile
Paran Sarimita Winarni
Sachin Atre
Joe Burzynski
Marian Loveday
4:15 Diana Stanley: Publishing TB research: The best science for better lives
4:30 New TB Trials/Therapeutic Pipeline, New Regimens
Chairs: Neel Gandhi, Kelly Dooley
Panel Members:
Mel Spigelman
Molly Franke
Lindsay Mckenna
Tim Walker
Christopher Cousins
5:30 Closing Remarks: Salim Abdool Karim
March 21st, 2024
8:45 Robert Horsburgh: Opportunities for Prevention of TB Drug Resistance
9:00 Eric Nuermberger: Insights from murine model on new regimens
9:15 Uma Devi Ranganthan: Effectiveness and Safety of varying Doses of Linezolid with Bedaquiline and Pretomanid in Adults with Pre-Extensively Drug-Resistant Pulmonary Tuberculosis: Preliminary report
9:30 Gunar Günther: Evolving Bedaquiline resistance in the field – example from Namibia
Short Presentations
10:10 Debrah Vambe: Integration of targeted sequencing into national diagnostic and treatment algorithm in Eswatini
10:20 Phumeza Tisile: Insights from a TB Champion on South Africa's TB Policies
10:30 Boitumelo Seepamore: Adherence support interventions for key MDR-TB HIV infected populations
11:00 Morten Ruhwald Designing molecular diagnostics for current tuberculosis drug regimens
11:10 Helen Jenkins: Risk of emergence of rifampicin-resistance after loss to follow-up from tuberculosis treatment
11:20 Salome Charalambous: Digital Adherence tools for TB – experience from TB Mate and ASCENT projects
11:30 David Branigan: What is needed to realize universal access to TB drug-susceptibility testing as a human right?
11:40 Jennifer Furin: Prioritizing Person-Centered Tuberculosis Care: Urgent Actions to Combat Drug-Resistance
11:50 Dorothy Yeboah-Manu: Insights into drug resistance TB in Ghana, West Africa
1:00 Early Career Scientist Research Presentations 1
Chairs: Carole Mitnick, Dorothy Yeboah-Manu
Presenters:
Karl Reis
James Millard
Esmerelda Reyes
Noriah Maraba
Jonathan Stillo
1:00 Early Career Scientist Research Presentations 2
Chairs: Luke Davis, Kelly Dooley
Presenters:
Kathleen Walsh
Camus Nimmo
Allison Wolf
Saranathan Rajagopalan
Dessa Casalme
2:00 Prevention of MDR-TB /Pediatrics
Chair: Yael Hirsch-Moverman
Panel Members:
Salome Charalambous
Paran Sarimita Winarni
Marian Loveday
Rovina Ruslami
2:00 Molecular basis of resistance to the new drugs
Chair: Michelle Larsen
Panel Members:
Camus Nimmo
James Millard
Uma Devi Ramalingam
Timothy Walker